As of 2025-09-18, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (17.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -39153.7%.
The range of the Relative Valuation is (15.50) - (19.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 15.5x | 13.9x |
| Forward P/E multiples | 12.2x - 20.1x | 13.8x |
| Fair Price | (15.50) - (19.49) | (17.46) |
| Upside | -34783.1% - -43693.6% | -39153.7% |
| Date | P/E |